The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Colony stimulating factor-1 receptor is a central component of the foreign body response to biomaterial implants in rodents and non-human primates
Open accessAbstract
Host recognition and immune-mediated foreign body response to biomaterials can compromise the performance of implanted medical devices. To identify key cell and cytokine targets, here we perform in-depth systems analysis of innate and adaptive immune system responses to implanted biomaterials in rodents and non-human primates. While macrophages are indispensable to the fibrotic cascade, surprisingly neutrophils and complement are not. Macrophages, via CXCL13, lead to downstream B cell recruitment, which further potentiated fibrosis, as confirmed by B cell knockout and CXCL13 neutralization. Interestingly, colony stimulating factor-1 receptor (CSF1R) is significantly increased following implantation of multiple biomaterial classes: ceramic, polymer and hydrogel. Its inhibition, like macrophage depletion, leads to complete loss of fibrosis, but spares other macrophage functions such as wound healing, reactive oxygen species production and phagocytosis. Our results indicate that targeting CSF1R may allow for a more selective method of fibrosis inhibition, and improve biomaterial biocompatibility without the need for broad immunosuppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CSF1 receptor has been recently identified as playing a unique role in FBR-associated inflammation, with its inhibition using both implant-encapsulated and systemically-delivered small molecule compounds leading to a decrease in macrophage activity and fibrosis around implanted materials without impacting wound healing (Doloff et al., 2017; Farah et al., 2019).”
From Foreign Body Reaction to Implanted Biomaterials and Its Impact in Nerve Neuroprosthetics (2021) · cites this paper as Doloff et al., 2017
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies using immune cell knockouts in animal models have identified macrophages as the primary drivers of fibrous capsule formation 5 .”
From Soft tissue-mimicking hydrogel stiffness modulates polarisation of human monocyte-derived macrophages (2025) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030
Kurtz, S. M., Ong, K. L., Lau, E., Mowat, F. S., & Halpern, M. T. (2007) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.f.00222 · Cited by 8,714
Alginate: Properties and biomedical applications
Lee, K. Y., & Mooney, D. J. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.06.003 · Cited by 8,477
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells
Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., Ueyama, Y., Koyanagi, Y., Sugamura, K., Tsuji, K., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0207 · Cited by 1,483
Veiseh, O., Doloff, J. C., Ma, M., Vegas, A. J., Tam, H. H., Bader, A. R., Li, J., Langan, E., Wyckoff, J., Loo, W. S., et al. (2015) · Nature Materials · doi:10.1038/nmat4290 · Cited by 897
Self-citationMacrophages and Tissue Injury: Agents of Defense or Destruction?
Laskin, D. L., Sunil, V. R., Gardner, C. R., & Laskin, J. D. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105812 · Cited by 625
A Review of Organic and Inorganic Biomaterials for Neural Interfaces
Fattahi, P., Yang, G., Kim, G., & Abidian, M. R. (2014) · Advanced Materials · doi:10.1002/adma.201304496 · Cited by 580
Vegas, A. J., Veiseh, O., Doloff, J. C., Ma, M., Tam, H. H., Bratlie, K., Li, J., Bader, A. R., Langan, E., Olejnik, K., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3462 · Cited by 551
Self-citationAlginate-based microcapsules for immunoisolation of pancreatic islets
de Vos, P., Faas, M. M., Strand, B. L., & Calafiore, R. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.07.010 · Cited by 511
First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip
Farra, R., Sheppard, N. F., McCabe, L., Neer, R. M., Anderson, J., Santini, J. T., Cima, M. J., & Langer, R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003276 · Cited by 449
Self-citationRegulatory immune cells in transplantation
Wood, K. J., Bushell, A., & Hester, J. (2012) · Nature reviews. Immunology · doi:10.1038/nri3227 · Cited by 442
Sussman, E. M., Halpin, M. C., Muster, J., Moon, R. T., & Ratner, B. D. (2014) · Annals of Biomedical Engineering · doi:10.1007/s10439-013-0933-0 · Cited by 416
Biocompatible Materials for Continuous Glucose Monitoring Devices
Nichols, S. P., Koh, A., Storm, W. L., Shin, J. H., & Schoenfisch, M. H. (2013) · Chemical Reviews · doi:10.1021/cr300387j · Cited by 347
The IL-21 receptor augments Th2 effector function and alternative macrophage activation
Pesce, J. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27727 · Cited by 344
Ward, W. K. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200504 · Cited by 337
Safety and Viability of Microencapsulated Human Islets Transplanted Into Diabetic Humans
Tuch, B., Keogh, G., Williams, L., Wu, W., Foster, J., Vaithilingam, V., & Philips, R. (2009) · Diabetes Care · doi:10.2337/dc09-0744 · Cited by 329
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Affara, N. I., Ruffell, B., Medler, T. R., Gunderson, A. J., Johansson, M., Bornstein, S., Bergsland, E. K., Steinhoff, M. S., Li, Y., Gong, Q., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.026 · Cited by 314
Macroscale delivery systems for molecular and cellular payloads
Kearney, C. J., & Mooney, D. J. (2013) · Nature Materials · doi:10.1038/nmat3758 · Cited by 302
Combating medical device fouling
Harding, J. L., & Reynolds, M. M. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.12.004 · Cited by 269
Carlsen, H. S., Bækkevold, E. S., Morton, H. C., Haraldsen, G., & Brandtzæg, P. (2004) · Blood · doi:10.1182/blood-2004-02-0701 · Cited by 266
Conway, J. G., McDonald, B., Parham, J. H., Keith, B. R., Rusnak, D. W., Shaw, E., Jansen, M., Lin, P., Payne, A. J., Crosby, R. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502000102 · Cited by 249
Jacobs‐Tulleneers‐Thevissen, D., Chintinne, M., Ling, Z., Gillard, P., Schoonjans, L., Delvaux, G., Strand, B. L., Gorus, F., Keymeulen, B., & PIPELEERS, D. G. (2013) · Diabetologia · doi:10.1007/s00125-013-2906-0 · Cited by 238
Kyriakides, T. R., Foster, M. J., Keeney, G. E., Tsai, A., Giachelli, C. M., Clark-Lewis, I., Rollins, B. J., & Bornstein, P. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63265-8 · Cited by 226
C-X-C Motif Chemokine 13 (CXCL13) is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis
Vuga, L. J., Tedrow, J. R., Pandit, K. V., Tan, J., Kass, D. J., Xue, J., Chandra, D., Leader, J. K., Gibson, K. F., Kaminski, N., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1592oc · Cited by 205
Mediators of the inflammatory response to joint replacement devices
COBELLI, N. J., Scharf, B., Crisi, G. M., Hardin, J., & Santambrogio, L. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.128 · Cited by 199
All charged up about implanted biomaterials
Grainger, D. W. (2013) · Nature Biotechnology · doi:10.1038/nbt.2600 · Cited by 187
Adverse effects of bisphosphonates: current issues.
Diel, I., Bergner, R., & Grötz, K. A. (2007) · PubMed · Cited by 162
Perspectives and Challenges in Tissue Engineering and Regenerative Medicine
Langer, R. (2009) · Advanced Materials · doi:10.1002/adma.200902589 · Cited by 161
Self-citationNeutrophil Responses to Sterile Implant Materials
Jhunjhunwala, S., Aresta-Dasilva, S., Tang, K., Álvarez, D., Webber, M. J., Tang, B. C., Lavin, D. M., Omid Veiseh, A., Doloff, J. C., Bose, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137550 · Cited by 133
Self-citationDang, T. T., Thai, A. V., Cohen, J., Slosberg, J. E., Siniakowicz, K., Doloff, J. C., Ma, M., Hollister-Lock, J., Tang, K. M., Gu, Z., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.016 · Cited by 125
Self-citationAttur, M. G., Patel, R., Thakker, G. D., Vyas, P., Levartovsky, D., Patel, P., Naqvi, S., Raza, R., Patel, K., Abramson, D., et al. (2000) · Inflammation Research · doi:10.1007/pl00000199 · Cited by 122
Rosen, M. R., Robinson, R. B., Brink, P. R., & Cohen, I. S. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.120 · Cited by 122
Focal Controlled Drug Delivery
Domb, A. J., & Khan, W. (2014) · Advances in delivery science and technology · doi:10.1007/978-1-4614-9434-8 · Cited by 122
Khan, W., Muntimadugu, E., Jaffé, M., & Domb, A. J. (2013) · Advances in delivery science and technology · doi:10.1007/978-1-4614-9434-8_2 · Cited by 114
Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites
Rodriguez, A., Meyerson, H., & Anderson, J. M. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31939 · Cited by 111
Translating materials design to the clinic
Hubbell, J. A., & Langer, R. (2013) · Nature Materials · doi:10.1038/nmat3788 · Cited by 102
Self-citationIslet encapsulation: advances and obstacles
Weir, G. C. (2013) · Diabetologia · doi:10.1007/s00125-013-2921-1 · Cited by 82
CX3CR1 deficiency promotes muscle repair and regeneration by enhancing macrophage ApoE production
Arnold, L., Perrin, H., de Chanville, C. B., Saclier, M., Hermand, P., Poupel, L., Guyon, E., Licata, F., Carpentier, W., Vilar, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9972 · Cited by 78
Timp-1 is a Key Factor of Fibrogenic Response to Bleomycin in Mouse Lung
Manoury, B., Caulet-Maugendre, S., Guénon, I., Lagente, V., & Boichot, E. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200601900303 · Cited by 77
Inflammatory response to peritoneal implantation of alginate–poly-l-lysine microcapsules
Robitaille, R., Dusseault, J., Henley, N., Desbiens, K., Labrecque, N., & Hallé, J. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.028 · Cited by 68
Paredes-Juarez, G. A., de Haan, B. J., Faas, M. M., & de Vos, P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.009 · Cited by 68
Rapid Biocompatibility Analysis of Materials via In Vivo Fluorescence Imaging of Mouse Models
Bratlie, K. M., Dang, T. T., Lyle, S. R., Nahrendorf, M., Weissleder, R., Langer, R., & Anderson, D. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010032 · Cited by 64
Self-citationNeale, S. D., & Athanasou, N. A. (1999) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679909000980 · Cited by 62
The posterior chamber phakic refractive lens (PRL): a review
Pérez-Cambrodí, R. J., Pinero, D. P., Ferrer‐Blasco, T., Cerviño, A., & Brautaset, R. (2012) · Eye · doi:10.1038/eye.2012.235 · Cited by 40
Shen, M., & Horbett, T. A. (2001) · Journal of Biomedical Materials Research · doi:10.1002/1097-4636(20011205)57:3
Flagged first, then by citations
Research works printed but not linked: 1
- Med, I. Medical Devices and the Public’s Health: The FDA 510(k) Clearance Process at 35 Years 1–298 (National Academies, 2011).
Cited by
Sorted by citations
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 890
Self-citationBiofabrication strategies for 3D in vitro models and regenerative medicine
Moroni, L., Burdick, J. A., Highley, C., Lee, S. J., Morimoto, Y., Takeuchi, S., & Yoo, J. J. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0006-y · Cited by 753
Biomaterials: Foreign Bodies or Tuners for the Immune Response?
Mariani, E., Lisignoli, G., Borzì, R. M., & Pulsatelli, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030636 · Cited by 706
Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing
Griffin, D. R., Archang, M. M., Kuan, C., Weaver, W. M., Weinstein, J. S., Feng, A., Ruccia, A., Sideris, E., Ragkousis, V., Koh, J., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-00844-w · Cited by 524
Foreign Body Reaction to Implanted Biomaterials and Its Impact in Nerve Neuroprosthetics
Carnicer-Lombarte, A., Chen, S.-T., Malliaras, G. G., & Barone, D. G. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.622524 · Cited by 454
“CSF1 receptor has been recently identified as playing a unique role in FBR-associated inflammation, with its inhibition using both implant-encapsulated and systemically-delivered small molecule compounds leading to a decrease in macrophage activity and fibrosis around implanted materials without impacting wound healin…”
Background
Metadata
- Authors
- Doloff, J. C., Veiseh, O., Vegas, A. J., Tam, H. H., Farah, S., Ma, M., Li, J., Bader, A., Chiu, A., Sadraei, A., Aresta-Dasilva, S., Griffin, M., Jhunjhunwala, S., Webber, M., Siebert, S., Tang, K., Chen, M., Langan, E., Dholokia, N., Thakrar, R., Qi, M., Oberholzer, J., Greiner, D. L., Langer, R., & Anderson, D. G.
- Affiliations
- Boston Children's Hospital (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- University of Illinois Chicago (US)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Anderson, Daniel G.
- ORCID
- Venue
- Nature Materials
- Published
- 2017-03-20
- Volume
- 16
- Issue
- 6
- Pages
- 671-680
- ISSN
- 1476-1122 (ISSN-L)
- 1476-4660
- PMC
- PMC5445003
- OpenAlex
- W2599718320
- Cited by
- 283
- References
- 50
- Citations by year
- 2026: 28 · 2025: 29 · 2024: 26 · 2023: 33 · 2022: 33 · 2021: 39 · 2020: 19 · 2019: 42 · 2018: 20 · 2017: 14
- FWCI
- 26.59
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-05-19)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Materials (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institutes of Health (4r37eb000244-34, 1uc4dk104218-01)
- National Cancer Institute (U54CA151884, P30CA014051)
- National Institute of Diabetes and Digestive and Kidney Diseases (UC4-DK-104218, U01DK104218, R01DK091526)
- National Institute of Biomedical Imaging and Bioengineering (R01EB000244, R37-EB000244, R01EB000351)
- National Institute of Dental and Craniofacial Research (R01DE013023)
- Topics
- Health Sciences › Medicine › Surgery › Orthopaedic implants and arthroplasty
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Keywords
- colony-stimulating factor 1 receptor, foreign body reaction, implantable biomaterials, implant biocompatibility, macrophages, fibrosis, CXCL13, B cell recruitment, CSF1R inhibition, non-human primates, rodents, hydrogels, polymers, ceramics, innate and adaptive immunity
- MeSH terms
- Animals, Biocompatible Materials, Foreign-Body Reaction, Primates, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Prostheses and Implants, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
